Literature DB >> 29393705

Alpha-1 Antitrypsin Deficiency Detection in a Portuguese Population.

Leonor Meira1, Rita Boaventura1, Susana Seixas2,3, Maria Sucena1.   

Abstract

Alpha-1 antitrypsin deficiency (AATD) is an autosomal co-dominant disease characterised by low serum levels of this molecule. Its epidemiology remains unknown in many countries, mainly due to its underdiagnosed state and lack of patients' registries. We aim to evaluate and characterise a sample of Portuguese individuals tested for AATD, between 2006 and 2015, based on a retrospective analysis from the database of a laboratory offering AATD genetic diagnosis service. 1684 individuals were considered, covering almost every region in Portugal. Genetic diagnosis resulted from requests of clinicians from different areas of expertise, mainly pulmonology (35.5%). Most subjects could be distributed into more common genotypes: MZ (25.4%, n = 427), MS (15.5%, n = 261), SZ (11.2%, n = 188), ZZ (9.4%, n = 158) and SS (5.6%, n = 95). 9.5% of the subjects were found to carry at least one rare deleterious allele, including the recently described PGaia, Q0Oliveira do Douro, Q0Vila Real and a novel SGaia variant. This study comprises 417 subjects (24.7%) with severe to very severe AATD and 761 carriers (45.2%), 22.7% of those identified by familial screening. The present study represents the most complete survey of AATD in Portugal so far and discloses a high rate of severe and very severe deficiency cases, attributed not only to ZZ and SZ genotypes but also to a large number of rare combinations with other null and deficiency alleles. It also uncovers a low awareness to AATD among the medical community, highlighting the need to create a Portuguese national registry and AATD guidelines and increase the awareness about this condition.

Entities:  

Keywords:  AATD registry; Alpha-1 antitrypsin deficiency (AATD); deficiency alleles; genetic screening

Mesh:

Substances:

Year:  2018        PMID: 29393705     DOI: 10.1080/15412555.2017.1414779

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  5 in total

1.  Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.

Authors:  José Luis Lopez-Campos; Lourdes Osaba; Karen Czischke; José R Jardim; Mariano Fernandez Acquier; Abraham Ali; Hakan Günen; Noelia Rapun; Estrella Drobnic; Marc Miravitlles
Journal:  Respir Res       Date:  2022-06-10

Review 2.  Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.

Authors:  Susana Seixas; Patricia Isabel Marques
Journal:  Appl Clin Genet       Date:  2021-03-22

3.  A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report.

Authors:  Miguel Afonso; Clara Silva; Inês Pinho; Artur Vale; Ana Fernandes
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

4.  Clinical characterization of a novel alpha1-antitrypsin null variant: PiQ0Heidelberg.

Authors:  Maria A Presotto; Martina Veith; Frederik Trinkmann; Kai Schlamp; Markus Polke; Ralf Eberhardt; Felix Herth; Franziska C Trudzinski
Journal:  Respir Med Case Rep       Date:  2022-01-03

5.  Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.

Authors:  Irene Belmonte; Alexa Nuñez; Miriam Barrecheguren; Cristina Esquinas; Mònica Pons; Rosa M López-Martínez; Gerard Ruiz; Albert Blanco-Grau; Roser Ferrer; Joan Genescà; Marc Miravitlles; Francisco Rodríguez-Frías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.